These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4917978)

  • 21. Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome.
    Mirsalis JC; Schindler-Horvat J; Hill JR; Green CE; Mitoma C; Tomaszewski JE; Tyson CA; Donohue SJ
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):193-201. PubMed ID: 12655436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Side effects of antileukemic therapy].
    La Grutta A; Lo Curto M
    Minerva Pediatr; 1983 Apr; 35(7):313-23. PubMed ID: 6346035
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-rheumatic efficacy of naproxen.
    Philip J; Joseph PP; Das KV
    J Assoc Physicians India; 1982 Sep; 30(9):593-6. PubMed ID: 6764215
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment with 5-fluorouracil: randomized study comparing an oral preparation with intravenous administration].
    Veronesi A; Talamini R; Mauro Trovò G; Tirelli U; Galligioni E; Tumolo S; Grigoletto E
    Clin Ter; 1981 May; 97(4):389-93. PubMed ID: 7018819
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma.
    Samson MK; Baker LH; Cummings G; Talley RW; McDonald B; Bhathena DB
    Cancer Treat Rep; 1982 Feb; 66(2):371-3. PubMed ID: 6459845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic chemotherapy of pancreatic cancer].
    Ozaki H; Ishii K
    Gan No Rinsho; 1972 Mar; ():Suppl:382-4. PubMed ID: 5064858
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical pharmacology of paclitaxel (Taxol).
    Rowinsky EK; Donehower RC
    Semin Oncol; 1993 Aug; 20(4 Suppl 3):16-25. PubMed ID: 8102014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
    Becker-Christensen F; Bang HO; Ditzel J
    Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental studies on the tolerance of Vanquin (Povan)].
    Gladkikh VF; Lebedeva MN; Lychko ND; Sazonova EV
    Med Parazitol (Mosk); 1969; 38(6):676-9. PubMed ID: 5373443
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical studies on intravenous administration of cephalothin--evaluation of the clinical data before and after cephalothin injection].
    Takayasu H; Kishimoto T; Aso Y; Miyamura R; Koiso K
    Saishin Igaku; 1971 Apr; 26(4):803-12. PubMed ID: 5114819
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dental clinical trial of a chlorhexidine-based mouthwash].
    Rapisarda E; Gismondo MR; Romeo MA; Terranova P
    Minerva Stomatol; 1984; 33(5):881-7. PubMed ID: 6394992
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).
    Hansen HH; Selawry OS; Muggia FM; Walker MD
    Cancer Res; 1971 Mar; 31(3):223-7. PubMed ID: 4926242
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical findings on the therapeutic action of a long-acting anabolic agent.
    Luppino V
    Panminerva Med; 1965 Oct; 7(10):392-8. PubMed ID: 5320934
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of oral aclarubicin treatment for tumors of the gastrointestinal track.
    Kagawa D; Nakamura T; Ueda T; Domae N; Uchino H
    Anticancer Res; 1993; 13(4):909-13. PubMed ID: 8352559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous anesthesia.
    Zauder HL; Nichols RJ
    Clin Anesth; 1969; 3():317-57. PubMed ID: 5001180
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
    Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
    Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
    [No Abstract]   [Full Text] [Related]  

  • 37. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
    Rosenthal DI; Nurenberg P; Becerra CR; Frenkel EP; Carbone DP; Lum BL; Miller R; Engel J; Young S; Miles D; Renschler MF
    Clin Cancer Res; 1999 Apr; 5(4):739-45. PubMed ID: 10213207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical use of N,N' -diethylene-N"-(5 methyl-1,3,4-thiadiazol-2-yl)-phosphoramide (S-261) in malignant tumors].
    Saito T; Ohira S; Wakui A; Endo H; Saito C
    Gan No Rinsho; 1966 Oct; 12(10):619-27. PubMed ID: 6009335
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of androgenic hormone combined with hydroxyurea (NSC-32065) on hematopoietic system of patients with cancer.
    Kennedy BJ; Newton K
    Cancer Chemother Rep; 1965 Dec; 49():21-5. PubMed ID: 5322836
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical research on the hepatoprotective and antianemic action of hepatic opotherapy associated with nucleosides in high doses].
    Bestagno M
    Arch Maragliano Patol Clin; 1966; 22(3):299-309. PubMed ID: 5953073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.